Skip to content
OpenCapital
Get started

Aurinia Pharmaceuticals AUPH Net product sales — Revenue

Other product segments

License, collaboration and royalty revenue
$4.14M+66.1%

Similar metrics at other companies

Supernus Pharmaceuticals logo
SUPNNet product sales — Total revenues
$150.75M+6.2%
BioCryst Pharmaceuticals logo
BCRXProduct sales, net — Total revenues
$151.4M+5.3%
Neurocrine Biosciences logo
NBIXNet product sales — Total revenues
$811M+43.9%
Bristol-Myers Squibb logo
BMYNet product sales — Total Revenues
$11.17B+2.6%
Tarsus Pharmaceuticals, Inc. logo
TARSProduct sales, net — Total revenues
$145.39M+85.6%
Travere Therapeutics, Inc. logo
TVTXTotal net product sales — Total Revenue
$124.49M+64.1%

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.3B+78.5%
Enterprise value$2.34B+78.3%
P/E7.7×-24.6×
P/S7.7×+2.5×

Profitability

See full
Gross margin89.7%+1.5pp
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's net product sales — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's net product sales — revenue?
Aurinia Pharmaceuticals (AUPH) reported net product sales — revenue of $73.56M in Q1 2026.
How has Aurinia Pharmaceuticals's net product sales — revenue changed year-over-year?
Aurinia Pharmaceuticals's net product sales — revenue increased by 22.7% year-over-year, from $59.97M to $73.56M.
What is the long-term trend for Aurinia Pharmaceuticals's net product sales — revenue?
Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's net product sales — revenue has grown at a 56.3% compound annual growth rate (CAGR), from $45.49M to $271.35M.
What does net product sales — revenue mean?
This metric represents the total revenue generated from the direct sale of pharmaceutical products to customers, net of allowances, rebates, and discounts. It serves as a primary indicator of market adoption and commercial success for the company's therapeutic portfolio. Tracking this figure helps investors evaluate the growth trajectory and commercial scalability of the firm's core product offerings.